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Background: Physical inactivity and overweight are two known risk factors for postmenopausal breast cancer.
Former exercise intervention studies showed that physical activity influences sex hormone levels, known to be
related to postmenopausal breast cancer, mainly when concordant loss of body weight was achieved. The question
remains whether there is an additional beneficial effect of physical activity when weight loss is reached.
The aim of this study is to investigate the effect attributable to exercise on postmenopausal breast cancer risk
biomarkers, when equivalent weight loss is achieved compared with diet-induced weight loss.
Design: The SHAPE-2 study is a three-armed, multicentre trial. 243 sedentary, postmenopausal women who are
overweight or obese (BMI 25–35 kg/m2) are enrolled. After a 4-6 week run-in period, wherein a baseline diet is
prescribed, women are randomly allocated to (1) a diet group, (2) an exercise group or (3) a control group. The aim
of both intervention groups is to lose an amount of 5–6 kg body weight in 10–14 weeks. The diet group follows an
energy restricted diet and maintains the habitual physical activity level. The exercise group participates in a 16-week
endurance and strength training programme of 4 hours per week. Furthermore, they are prescribed a moderate
caloric restriction. The control group is asked to maintain body weight and continue the run-in baseline diet.
Measurements include blood sampling, questionnaires, anthropometrics (weight, height, waist and hip
circumference), maximal cycle exercise test (VO2peak), DEXA-scan (body composition) and abdominal MRI
(subcutaneous and visceral fat). Primary outcomes are serum levels of oestradiol, oestrone, testosterone and sex
hormone binding globulin (SHBG).
Discussion: This study will give insight in the potential attributable effect of physical activity on breast cancer risk
biomarkers and whether this effect is mediated by changes in body composition, in postmenopausal women.
Eventually this may lead to the design of specific lifestyle guidelines for prevention of breast cancer.
Trial registration: The SHAPE-2 study is registered in the register of clinicaltrials.gov, Identifier: NCT01511276.Background
There is strong evidence that physical inactivity is asso-
ciated with a higher postmenopausal breast cancer risk
[1,2]. In contrast to most other risk factors, physical ac-
tivity provides an opportunity for primary prevention.
The causal pathway through which exercise influences
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The evidence that oestrogens (endogenous as well as ex-
ogenous) contribute to breast cancer risk is strong and
widely accepted [4-6]. Postmenopausal women with ele-
vated levels of androgens also showed increased risk of
developing breast cancer, even after adjustment for
oestrogens [5-7]. In many cross-sectional observational
studies, a low level of physical activity has been associ-
ated with higher serum concentrations of sex hormones
in postmenopausal women [7-14], but not in all [15,16].
Physical activity might also influence postmenopausal
sex hormones by increasing levels of sex hormonentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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unbound (free) active oestrogens and androgens in the
circulation [10,11,14,17].
The beneficial effect of exercise on breast cancer
related biomarkers might be partly explained by
exercise-induced fat loss and prevention of becoming
overweight or obese. Observational studies show associ-
ations between body mass index (BMI) and oestrogen
levels in postmenopausal women [8-12]. Compared with
normal-weight women, obese postmenopausal women
have a higher blood concentration of oestrogens [12,13]
and lower concentrations of SHBG resulting in increased
levels of free oestradiol [12,14-16,18]. The association
between BMI and androgens is less clear, i.e. cross-
sectional studies reported conflicting results [10,19-21].
In our previous SHAPE trial we found that in the exer-
cise group, reductions of sex hormone levels mainly
occur when concordant loss of body fat was achieved
[22]. These findings were in concordance with results
from a comparable exercise intervention study [23,24].
Another exercise intervention study [25], however, found
an overall intervention effect of exercise on sex hor-
mones, which might be explained by the fact that in this
study the overall difference in weight reduction between
the intervention and control group was much greater
compared with the earlier trials. A fourth trial investigat-
ing the effects of dietary, exercise and combined weight
loss interventions, found that greater weight loss pro-
duced stronger effects on oestrogens and SHBG [26].
The question remains whether the beneficial effect of
physical activity on breast cancer risk is fully explained
by the accompanied weight loss, or whether physical ac-
tivity has an additional positive effect on hormones.
Therefore, we set out to study the effect of weight loss
mainly driven by exercise compared with equivalent weight
loss driven by a diet only, on breast cancer risk biomarkers.
Furthermore, we are specifically interested whether weight
loss due to physical exercise induces greater amounts of fat
loss (total and abdominal) and subsequently results in
stronger favourable effects on relevant hormones com-
pared with equivalent diet-induced weight loss.
Methods/design
The aim of the SHAPE-2 study is to investigate the effect
attributable to exercise on postmenopausal breast cancer
risk biomarkers, when equivalent weight loss is achieved
compared with diet-induced weight loss. The secondary
aim is to study the effects of equivalent weight loss
achieved by calorie reduced diet or by increased physical
activity on body composition and fat distribution and
whether this mediates sex hormone levels.
The SHAPE-2 study is designed as a three-armed,
randomised controlled trial. The study programme runs
in eight municipalities surrounding two research centresin the middle (Utrecht) and the east (Enschede) of the
Netherlands. The total study duration for each study
participant is about 21 weeks. After a 4–6 week run-in
period, eligible women are randomly allocated to (1) a
diet group; (2) an exercise group or (3) a waiting list
control group. Both intervention groups have the aim to
lose an amount of 5–6 kg of bodyweight in 10–14 weeks.
The intervention period is followed by a weight main-
tenance period lasting at least 2 weeks.
The study protocol is approved by the Medical Ethics
Committee of University Medical Centre Utrecht, in ac-
cordance with the Helsinki declaration, before the start
of data collection.
Study population
A total of 250 postmenopausal women, aged 50–69 years,
are included. Eligible women are overweight or obese
(BMI 25–35 m/kg2), have a sedentary lifestyle and live in
the middle or east of the Netherlands.
Postmenopausal state is defined as natural cessation of
menses for at least 12 months, or in case of hysterec-
tomy: aged 55+ and likely to be postmenopausal based
on medical history. Sedentary is defined as less than
2 hours of moderate-to-vigorous physical activity per
week (≥4 metabolic equivalents (MET)) [27]. Energy ex-
penditure from occupational activity (except for highly
active jobs e.g. courier, sports instructor), walking at
moderate pace and cycling as a transport medium
(<16 km/hour) are not considered. In case of doubt, in-
dividuals are discussed in the study team. Exclusion cri-
teria are factors that either interfere with endogenous
sex hormone levels or successful completion of the diet
or exercise intervention (see Table 1).
Recruitment and screening
Study participants are mainly recruited by invitation let-
ters explaining the study goals and inclusion criteria.
These letters are sent to a random selection of female
inhabitants (aged 50–69 years, Dutch nationality) of the
participating municipalities: Zeist, Bilthoven, Utrecht,
Nieuwegein, Houten, IJsselstein, Enschede, and Oldenzaal.
Furthermore, we aim to publish articles in local newspa-
pers including calls for participants. Responding women
are contacted by phone by a study nurse to provide more
information and to further assess eligibility. Potential can-
didates are invited for a screening visit at the research unit
in their region, where informed consent is signed and BMI
and glucose (ACCU-CHEK® Aviva) are checked. Addition-
ally, motivation and physical ability to perform the exer-
cise programme are discussed. If eligible, the participant is
scheduled for the study dietitian and starts with the run-in
period. See Figure 1 for the flow chart of the recruitment
and inclusion procedure. All participating women gave in-
formed consent before start of the study.
Table 1 SHAPE-2 study inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Female Presently using sex hormones
50-69 years of age Use of beta-blockers or oral corticosteroids
Postmenopausal (last menses >12 months) Smoking
Body mass index (BMI) 25–35 m/kg2 Alcohol or drug abuse
Sedentary lifestyle (<2 hours/week of at least moderately intensive
activities (≥4 MET))
Diagnosed with breast cancer (present or history)
Willing to be randomly assigned to one of the three study arms Diagnosed with other cancer (present or <5 years of history), except for
non-melanoma skin cancer
Informed consent for all screening and study activities Diabetes mellitus or other (unstable) endocrine related diseases
Any disorder that might impede participation in the exercise programme
Following, or intention to follow, a structured weight loss programme
elsewhere
Investigators opinion (successful fulfilling of the programme is highly unlikely)
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During the 4–6 week run-in period, a baseline diet is
prescribed which resembles the habitual intake of the
participant and is in accordance with the Dutch Guide-
lines for a Healthy Diet [28] (50-60% carbohydrate, 15-
20% protein and 20-35% fat). The energy content of the
baseline diet is determined using the individual’s habitual
energy intake (dietary history), body weight history and
a calculated estimate using the Harris & Benedict for-
mula [29] multiplied by an estimate of their PhysicalMailing (n=16,080): 
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Figure 1 Flow-chart recruitment and inclusion procedure.Activity Level (PAL). Special attention is paid to alcohol
intake (maximum of one drink per day) and fibre intake
(minimum of 25 grams per day) since these may influ-
ence sex hormone levels [30-32]. The run in period and
the baseline diet aim to normalise the dietary pattern,
stabilise body weight, check the estimated energy
requirements and evaluate protocol adherence.
During the run-in, adherence to the programme is moni-
tored by filling out a 3-day food diary, weekly self-weighing
and telephone contacts with the dietitian (see Table 2).ation  
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Table 2 Overview study programme, contact moments and measurements
Run-in phase Intervention phase Maintenance
week −6 −5 −4 −3 −2 −1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Diet group
-diet composition Baseline diet Energy restricted diet (−500 kcal/day)
-dietary counselling* F T T F G T G T G T T G T F,
G
T
Exercise group
-diet composition Baseline diet Energy restricted diet (−250 kcal/day)
-dietary counselling* F T T F T T T T T F T
-exercise programme** Aerobic and strength training (4 hours/week)
E E E E E E E E E E E E E E E E
Control group
-diet composition Baseline diet Baseline diet
-dietary counselling* F T T T T T
Measurements***
-Habitual dietary intake (dietary history) X
-Actual dietary intake (3-day food records) X X X
-Habitual physical activity (questionnaires) X X
-Actual physical activity (accelerometer) X X
-Anthropometrics (weight, waist, hip circumference);
body composition (DEXA); visceral and subcutaneous
abdominal fat (MRI); fitness (maximal exercise test);
blood pressure; sex hormones (blood sampling)
X X
*dietary counselling: F = face-to-face individual counselling; T = individual counselling by telephone; G = group counselling session.
** exercise programme: E = group fitness and Nordic walking, 4 hours per week.
*** measurements: X = all participants.
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After successful completion of the run-in period, sub-
jects are randomised to (1) a diet group; (2) an exercise
group or (3) a waiting list control group. Randomisation
is performed via a computer-generated sequence, strati-
fied per municipality, in block sizes of 5 (ratio interven-
tions vs. control; 2:2:1).
The goal of both intervention programmes is to lose
an equivalent amount of 5–6 kg of body weight, in 10–
14 weeks’ time. The weight loss interventions are super-
vised by dietitians and physiotherapists, established in
each participating municipality.
Body weight is closely monitored in both intervention
groups by continuation of weekly self-weighing. Super-
vised weighing, by the dietitian (at every visit) and
physiotherapist (weekly), is performed in addition. Par-
ticipants, whose weekly weight loss do not meet or ex-
ceed the 0.5 kg/week loss for 3 consecutive weeks,
receive extra coaching to adapt their diet or exercise
level.
If the weight loss goal is reached, or after a maximum
of 14 weeks, a weight maintenance period (2–6 weeks)
starts in which energy intake and energy expenditure is
balanced by dietary adaptations. The goal of thismaintenance period is to establish stable weight in order
to obtain stable levels of sex hormones.
Diet group: weight loss induced by diet only
The weight loss intervention is delivered by registered
dietitians, experienced in treatment of overweight and
motivational interviewing. Motivational interviewing is a
client-centred counselling approach which is a proven
effective method used to increase motivation and to es-
tablish behaviour change [33,34].
Frequent contacts with the dietitian are scheduled (see
Table 2 for an overview of the study programme). After
randomisation, women individually meet their dietitian
for the prescription of a calorie restricted diet. The diet
has a deficit of 500 kcal/day as compared with the indi-
viduals energy requirements estimated at the run-in
period. The diet is composed of the same proportions of
macronutrients as the baseline diet conform National
Guidelines for a Healthy Diet [28]. Additionally, 5 one-
hour interactive group sessions are planned (maximal 12
women/group). The programme for these sessions is
based on principles of cognitive behavioural therapy [35]
and motivational interviewing [34] and consists of nutri-
tion education, behaviour change techniques and self-
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monitored by completing a 3-day food diary and fre-
quent telephone contacts with the dietitian (see Table 2).
Women in the diet group are requested to maintain
their habitual physical activity level.
Exercise group: weight loss mainly induced by exercise
Women randomised to the exercise group are enrolled in
a 16-week exercise training programme, delivered by
physiotherapists. Additionally, a moderate caloric restric-
tion of 250 kcal/day is prescribed by a dietitian in an indi-
vidual session. From recent literature, we know that
achieving and maintaining a body weight reduction by ex-
ercising in untrained and obese women is a long term
process and a goal hard to attain [36,37]. Compensatory
mechanisms both physically and mentally, and behavioural
reasons withhold the person from losing weight ad-
equately [38,39]. We, therefore, decided to study the effect
of exercise in combination with a slight diet energy deficit.
The prescribed diet is monitored by regular telephone
contacts with the dietitian. In this group, main emphasis is
placed on the exercise programme, which contains four
hours of moderate-to-vigorous exercise per week in group-
and individual sessions. The estimated energy expenditure
of the exercise programme is approximately 350 kcal/day,
based on corresponding MET rates [27]. For our specific
study population, we corrected METs for age [40,41].
The exercise protocol contains both endurance and
strength training. Levels of exercise intensity are grad-
ually increased during the study programme. Intensity of
strength training is determined by pragmatic 20- and
15-repetition maximum (RM) tests, performed several
times throughout the 16 weeks to adapt the resistance.
Intensity of endurance training is determined by the
heart rate reserve based on the guidelines of the Ameri-
can College of Sports Medicine, adapted for older
women [42]. Target heart rates are based on results of a
maximal exercise test and calculated by the formula: [in-
tensity%*(maximal heart rate – resting heart rate)] +Table 3 Group fitness training programme
Week Endurance
1-3 40-60% HRR*
4-8 60-70% HRR* 15–20 min,
Plus 70-89% HRR* 5–10 min
9-12 Interval training: 10 × 30 sec. vigorous to maximal exercise,
alternated with 1 min active rest
Plus 10 min 60-75% HRR* endurance
13-
16
Interval training: 2 circuits of 8 × 30 sec vigorous to maximal,
alternated with 1 min active rest
Plus 5 min 60-75% HRR* endurance
*HRR: Heart rate reserve.
#RM: Repetition maximum.resting heart rate. Study participants wear heart rate
monitors while exercising and receive a badge with indi-
vidually calculated target heart rate zones for a range of
training intensities.
During every training session, subjects fill in an exer-
cise log which is used as a tool to adhere to the protocol
and for monitoring by the physiotherapist.
Group exercise
Twice a week, subjects participate in a standardised one-
hour group session, facilitated by a physiotherapist.
Groups consist of 5–6 women. The group exercise ses-
sions include 20–25 minutes high-intensity endurance
training combined with 25 minutes strength training.
Classes start and end with a 5–10 minute warming up
and cooling down, respectively.
Endurance training is performed in circuits on several
exercise machines, e.g. a treadmill, cycle or cross-trainer.
Intensity is gradually increased (see Table 3).
The standardised strength training protocol includes
exercises for the major muscle groups which is also
performed in circuits (Table 3).
Individual exercise
For feasibility reasons, individual home-based exercise is
also included. It comprises two hours of Nordic walking
at 60-65% of the heart rate reserve. All participants re-
ceive Nordic walking poles and instructions. If due to
medical reasons Nordic walking is not desirable, a
proper alternative is sought, e.g. swimming laps or cyc-
ling (vigorous effort). Supervised lessons of Nordic walk-
ing by instructors are organised to increase motivation
and compliance. These sessions can be attended volun-
tarily, however, women are strongly encouraged to join.
Home-based Nordic walking sessions are registered in
an exercise-log, which are checked regularly by the
physiotherapist. Group sessions at the physiotherapists
office and Nordic walking lessons are regularly moni-
tored by the researchers.Strength
1 circuit of 20–25 repetitions. Weights based on 20-RM#
Exercises: legs (squat, lunges, calve raises), arms (biceps curl,
triceps extension), shoulder (shoulder press), thorax
(Barbell bench press), back (rowing). Abdomen: crunch 30–40 repetitions.
2 circuits of 15–20 repetitions. Weights based on 15-RM#
Exercises: legs (squat), arms (biceps curl, triceps extension), shoulder
(shoulder press), thorax (Barbell bench press), back (rowing).
Abdomen; crunch 30–40 repetitions; hoover 2× 45 seconds.
If in time calve raises and lunges can be added.
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Participants in the control group are requested to keep
their weight stable by adhering to the baseline diet, and
maintaining their habitual exercise pattern. They are of-
fered an alternative weight loss programme after the study
period, consisting of 4 dietary group sessions and several
exercise classes such as Nordic walking and/or fitness.
Outcomes and measurements
Study participants visit the research centre for measure-
ments twice: at baseline (i.e. the end of the run-in period)
and at the end of the study (see Table 2). Measurements
include blood sampling, anthropometrics: height (at base-
line), weight, waist- and hip circumference), a total body
DEXA scan, abdominal MRI, blood pressure and cardiore-
spiratory fitness. At every visit, information on medication
use is assessed. Furthermore, we assess information on
socio-demographic variables, general health, medical his-
tory, reproductive history and smoking history at baseline
by a self-constructed questionnaire.
Blood samples
Blood samples (30 ml) are drawn in order to determine
serum concentrations of oestradiol (total and free),
oestrone, testosterone and SHBG. After centrifugation,
samples are directly stored at −20°C and at −80°C within
one week. All samples from one individual will be analysed
in the same batch since the batch-to-batch variation can
be higher than any woman’s likely change in hormones
over the year [43]. Serum oestrogens and testosterone will
be determined by use of the LC-MS method, in the
UHSM, Manchester laboratory [44]. SHBG will be
measured by commercially available double-antibody
radioimmunoassay kits (Roche Cobas: SHBG-
03052001), performed in the laboratory ”Stichting
Huisartsenlaboratorium Oost” in Velp [45]. Techni-
cians are blinded to study allocation.
Anthropometrics and body composition
Body weight and height are measured while the subjects
wear light clothes without shoes. To measure body
weight, we use calibrated analogue balance and digital
balance scales (SECA®), depending on study centre. Sub-
jects are always measured on the same balance scale.
Analogue values are rounded to the nearest 0.5 kg.
Height is measured using a wall mounted tape measure
and rounded to the nearest 0.5 cm.
Waist circumference (to the nearest 0.5 cm) is mea-
sured standing at the midway between lower ribs and
iliac crest. Hip circumference (to the nearest 0.5 cm) is
measured standing over the buttocks. All measurements
are taken in duplicate and averaged.
Total body fat (kg) and fat percentage (%) are assessed by
a total body DEXA-scan (Lunar, Prodigy™). The DEXA scanmeasures body composition according to a three-
compartment model: fat mass, lean tissue, and bone
mineral content. The standard soft tissue analysis is
performed using software supplied by the manufacturer.
Visceral abdominal fat (VAT) and subcutaneous ab-
dominal fat (SAT) are measured by MRI (Philips,
Ingenia 1.5 T) with the use of the three-point IDEAL
method, described by Dixon [46].
Blood pressure
Blood pressure is measured by an automatic tonometer
(OMRON M4 +) after a minimum of 5 minutes rest. Mea-
surements are taken twice, with a 2-minute time interval.
Cardiorespiratory fitness
A maximal cycle exercise test with respiratory gas ana-
lysis is performed to measure cardiorespiratory fitness,
defined by the highest oxygen uptake during the test
(VO2peak).
All testing is conducted according to the ATS guide-
lines [47]. Subjects are tested on a bicycle ergometer
(Ergoline, type Ergoselect 200 P, CareFusion, Houten,
the Netherlands and Jaeger ER800®, Würtzburg,
Germany). Seat height is adjusted so that subject’s legs
are near full extension during each pedal revolution.
The ramp cycle test protocol starts with 2 minutes of
rest and 3 minutes of active rest (cycling without work-
load). The test phase consists of 24-second stages of
graded exercise. Workload increases with 12.5 Watt or
15 Watt at every step, depending on the predicted max-
imum Watt per subject. Pedalling speed is kept around
65 revolutions per minute (RPM). If participants fail to
keep up or drop below 40 RPM, the test is ended and
followed by a 2-minute recovery phase. The maximal
exercise test is performed under medical supervision.
During the test, a 12-lead electrocardiogram (ECG)
and respiratory data through breath-by-breath analysis
(Oxycon Pro®, Jaeger, by Care Fusion, Houten, The
Netherlands) are continuously measured. Heart rate is
determined from the ECG. Cuff blood pressure is moni-
tored before and throughout the exercise and recovery
phase. VO2peak is defined as the highest 15-second aver-
age of VO2 obtained at the end of the test and is
expressed as ml/min and ml/kg/min.
The goal of the maximal cycle exercise test is three-
fold. In addition to measuring cardiorespiratory fitness/
VO2peak, it also serves as a medical evaluation, and max-
imal heart rate is used to estimate training intensity for
women participating in the exercise programme.
Physical activity
Physical activity level is assessed with an activity monitor
(GT3X + Tri-Axis Actigraphy Monitor, ActiGraph®). This
non-invasive device provides information on individual
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iour, activity intensity levels, and METs. It is worn in 7
consecutive days during the run-in and maintenance
period.
Furthermore, validated physical activity questionnaires
are used to measure habitual activity level (PASE ques-
tionnaire) [48] and short-term physical activity level
(SQUASH questionnaire) [49] at baseline and at the end
of study.
Dietary intake
Habitual dietary intake is assessed at baseline using the
dietary history method. Actual dietary intake and adher-
ence to the diet plan are assessed using 3-day food
records (including 1 weekend day) during every study
period (run-in, intervention and maintenance, see
Table 2). Participants are instructed by the dietitian how
to complete the records. Filled-in records are checked
by the dietitian for completeness and can be discussed
with participants in the next telephone contact. Energy
intake and nutrient composition are calculated using the
Dutch Food Composition Database [50].
Sample size
Sample size calculations are based on the effect of the in-
terventions on the primary outcome, i.e. serum oestradiol
levels. The following comparisons will be made:
1) diet-induced weight loss versus exercise-induced
weight loss. 2) diet-induced weight loss versus control. 3)
exercise-induced weight loss versus control. First, we cal-
culated the sample size for the first comparison, i.e. diet-
induced weight loss (n = 85) versus exercise-induced
weight loss (n = 85), since the difference in oestradiol
levels between these groups is expected to be the smallest
(8%). Based on the estimated sample sizes, we calculated
the number of subjects needed in the control group (n =
36). The sample size of the control group can be much
smaller, since the expected difference with the interven-
tions groups is large (12% and 20%, respectively). The
sample size calculations resulted in the following esti-
mated numbers per group, taking into account 5% drop
out and 15% non-compliance: control group n = 45, diet
group n = 104 and exercise group n = 104.
Statistical analysis
Descriptive statistics will be used to characterise the
study population at baseline per study arm. Baseline and
end of study values of sex hormone levels, total body fat
and intra-abdominal body fat will be tabulated by treat-
ment group. Sex hormones will be log transformed and
geometric means will be presented if not normally
distributed.
The main analysis will be performed according to the
intention-to-treat principle, by linear regression analysis,where outcomes for patients are analysed by assigned
treatment, regardless of the level of adherence. As a sec-
ondary analysis, adherence will be examined as a poten-
tial modifier of the intervention effects.
A per-protocol analysis will be performed analysing
women who reached the weight loss goal only. Whether
changes in body fat (total, abdominal) mediate or mod-
erate intervention effects on sex hormone levels will be
explored.Discussion
In the SHAPE-2 study, we aim to investigate the poten-
tial effect of physical activity on biomarkers of breast
cancer risk (sex hormones), additional to weight loss.
We hypothesize that exercise-induced weight loss results
in a stronger decrease in serum sex hormones compared
with equivalent diet-induced weight loss and compared
with controls.
The goal of the intervention, and challenge in this
trial, is for subjects to lose an equivalent amount of 5–
6 kg of body weight in both intervention groups. Success
of the study depends heavily on subjects’ adherence and
motivation.
We implemented several strategies to increase adher-
ence and motivation of the study subjects. First, the
weight loss interventions are delivered by experienced
dietitians and physiotherapists, who are situated in the
municipality and easily accessible. For participants in the
intervention groups, we scheduled a high contact fre-
quency with the dietitian and physiotherapists which is
proven to be a relevant success factor for weight reduc-
tion [51]. Second, group sessions are implemented in
both intervention programmes which provide a combin-
ation of social support, a healthy dose of competition
and increase self-efficacy [52]. It is also suggested that
dietary group sessions produce greater weight loss effects
than individual counselling alone [53]. Groups are kept
small to secure enough room for interactions and tailoring
of the programme to the specific needs of the participants.
Third, to strengthen motivation of the participants and for
monitoring purposes, the researchers visit diet and exer-
cise group sessions regularly. Furthermore, participants re-
ceive newsletters about the study or related topics and the
study website is updated frequently.
Adherence of the control group is also a challenge.
We expect women allocated to the control group to be
disappointed since they have their mind set on losing
weight. This might lead to a change in lifestyle, either
conscious or unconscious, resulting in slight weight loss.
To anticipate, we repeatedly stress the importance of the
control group. Moreover, we offer an evenly attractive
alternative weight loss programme starting at the end of
the study.
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25–30 participants per municipality in a small time win-
dow, since the participants have to start simultaneously
with the group interventions. The first group starts at
the central research site in the Utrecht region. Inclusion
in the second participating region (Enschede) starts in
parallel. Consecutive groups within one region start after
a minimum time interval of 1 month.
Due to a consecutive inclusion of municipalities, the
winter season, summer holidays and national holidays (e.g.
Christmas) might affect the adherence of some study
groups. To retain compliance in order to achieve the same
weight loss goal, dietitians and physiotherapists will antici-
pate these circumstances. We pay extra attention to the
Nordic walking programme in winter since the colder cli-
mate and shorter days may threat compliance. We there-
fore provide more options for supervised Nordic walking
hours and reflective clothing in winter.
In our study, we will measure visceral and subcutaneous
abdominal fat by using MRI, which is a highly sensitive
technique to measure changes in (intra-)abdominal fat. A
side effect of the use of cross sectional imaging in healthy
subjects is that there is a risk of incidental findings. Rates
of over 30% have been described while the proportion of
subjects that might benefit from these findings is likely to
be much lower than the proportion that will have no or
even an adverse effect [54,55]. Outweighing the risk-
benefit ratio and ethical considerations [56], we decided
on the following procedure. The non-contrast enhanced
T1-weighted IDEAL scans are considered non-diagnostic
and therefore will not be routinely reviewed by a radiolo-
gist. If researchers encounter an apparent finding that
strikes them as a possible abnormality, the radiologist will
be consulted. When the finding is of potential clinical rele-
vance, the participant and their general practitioner will be
informed and advised on further work up.
Our trial is the first study especially designed to assess
the additional effect of exercise on sex hormone levels
when equivalent weight loss is achieved. Four former
exercise intervention studies in the field suggested an
interplay between sex hormones and body weight/fat
mass [22-26]. Greater weight loss produced greater ef-
fects on serum sex hormone levels and SHBG.
The question remains whether there is an additional ef-
fect of exercise on serum sex hormones, as breast cancer
risk biomarkers, when equivalent weight loss is reached.
In the SHAPE-2 study, we aim to investigate the potential
effect attributable to physical activity on postmenopausal
breast cancer risk biomarkers, in addition to weight loss.
Competing interests
This work is supported by the Dutch Cancer Society [UU 2010–4843]. The
support from the sponsor is unconditional, and the data collection, design,
management, analysis, interpretation and reporting will be performed without
their interference. We have no non-financial competing interests to disclose.Authors’ contributions
Authors WG, JI, PP, AS, AM, TT, JP and EM were involved in the study design.
TT, advised in the composition of the exercise programme. JI, EM and WG
composed the dietary programme. WV designed the MRI scan protocol. HW
supplied services and materials for exercise testing. WG, EM, PP and JS
participated in the management and coordination of the study. JP
participated in the coordination on the second research site. WG and EM
drafted the manuscript. All have been involved in revising the content of the
manuscript. All authors have read and approved the final manuscript.Authors’ information
Willemijn van Gemert, MD, works as a PhD candidate at the department of
epidemiology of the Julius Center. Jolein Iestra, PhD, is a dietitian at the
department of Public Health of the Julius Center. Petra Peeters, MD, PhD,
Evelyn Monninkhof, PhD, and Anne May, PhD are epidemiologists working at
the epidemiology department of the Julius Center. Albertine Schuit, PhD, is
an epidemiologist at the national institute of Health and VU university. Tim
Takken, PhD, is an exercise physiologist working at the UMC Utrecht. Wouter
B. Veldhuis, MD, PhD, is a radiologist working at the radiology department of
the UMC Utrecht. Job van der Palen, PhD, is an epidemiologist and works as
a scientific research coordinator in the Medical Spectrum Twente and as a
professor in evaluation and assessment in healthcare research at the
University Twente. Harriët Wittink, PhD, is a physiotherapist and professor
Lifestyle and Health at the faculty of health care, Utrecht University of
Applied Sciences.Acknowledgements
We would like to acknowledge the following people who have collected
data or contributed to the running of the study: Manon de Leeuw, Fien
Stern, Lydeke Zwart, Lizeth Vendrig, Marjon van der Meer, Gerry van Hemert,
Karen Menninga, Joke metselaars, Veronique Sauerwald, Renate Bloemen
Willemien Boersma, Silvia Achterberg, Petra Hemeltjen, Mirjam Floor, Roelof
Peters and Jolanda Spruit. We would like to thank Ria Bouwhuis, who as a
dietetic student was involved in composing the diet programme.
Furthermore, we would greatly like to thank all the study participants and
the participating physiotherapists and dietitians in Utrecht and Enschede
and surroundings.
This work was supported by the Dutch Cancer Society [UU 2003–2793] and
the Dutch Pink Ribbon Foundation [PR110032, PR110039]. The support from
the sponsors was unconditional, and the data collection, design,
management, analysis, interpretation and reporting were performed without
their interference.
Author details
1Julius Center for Health Sciences and Primary Care, University Medical
Center Utrecht, P.O. Box 85500 Hp, Str. 6.131, 3508 GA, Utrecht, The
Netherlands. 2Division of Public Health and Health Care, National Institute for
Public Health and the Environment, P.O. Box 1 3720 BA, Bilthoven, The
Netherlands. 3Department of Health Sciences and EMGO Institute for Health
and Care Research, VU University, Amsterdam, The Netherlands. 4Shared
Utrecht Pediatric Exercise Research (SUPER) Lab, Utrecht University, Utrecht,
The Netherlands. 5Child Development & Exercise Center, Wilhelmina
Children’s Hospital, University Medical Center Utrecht, P.O. Box 85500 Hp, Str.
6.131, 3508 GA, Utrecht, The Netherlands. 6Department of Radiology,
University Medical Center, P.O. Box 85500 Hp, Str. 6.131, 3508 GA, Utrecht,
The Netherlands. 7Medisch Spectrum Twente Hospital, Department of
Epidemiology, P.O. Box 50 000 7500 KA, Enschede, The Netherlands.
8Department of Research Methodology, Measurement, and Data Analysis,
University of Twente, Enschede, The Netherlands. 9Research group Lifestyle
and Health, Faculty of Health Care, Utrecht University of Applied Sciences,
P.O. Box 85182 3508 AD, Utrecht, The Netherlands.
Received: 2 May 2013 Accepted: 21 August 2013
Published: 23 August 2013References
1. World Cancer Research Fund, American Institute for Cancer Research: Food,
Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective.
Washington DC: AICR; 2007.
van Gemert et al. BMC Cancer 2013, 13:395 Page 9 of 10
http://www.biomedcentral.com/1471-2407/13/3952. Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW,
van Leeuwen FE: Physical activity and breast cancer: a systematic review.
Epidemiology 2007, 18:137–157.
3. Campbell KL, McTiernan A: Exercise and biomarkers for cancer prevention
studies. J Nutr 2007, 137:161S–169S.
4. Hankinson SE, Eliassen AH: Endogenous estrogen, testosterone and
progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol
Biol 2007, 106:24–30.
5. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A,
Bingham S, Khaw KT, et al: Postmenopausal serum androgens, oestrogens
and breast cancer risk: the European prospective investigation into cancer
and nutrition. Endocr Relat Cancer 2005, 12:1071–1082.
6. Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and
breast cancer in postmenopausal women: reanalysis of nine prospective
studies. J Natl Cancer Inst 2002, 94:606–616.
7. Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone
levels, mammographic density, and subsequent risk of breast cancer in
postmenopausal women. J Natl Cancer Inst 2007, 99:1178–1187.
8. Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ: Hormone and bone
mineral status in endurance-trained and sedentary postmenopausal
women. J Clin Endocrinol Metab 1988, 66:927–933.
9. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y,
Modugno F, Perri MG, Stanczyk FZ, Van HL, Wang CY: Relation of BMI
and physical activity to sex hormones in postmenopausal women.
Obesity (Silver Spring) 2006, 14:1662–1677.
10. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG: The epidemiology of
serum sex hormones in postmenopausal women. Am J Epidemiol 1989,
129:1120–1131.
11. Chan MF, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A,
Khaw KT: Usual physical activity and endogenous sex hormones in
postmenopausal women: the European prospective investigation into
cancer-norfolk population study. Cancer Epidemiol Biomarkers Prev 2007,
16:900–905.
12. Schmitz KH, Lin H, Sammel MD, Gracia CR, Nelson DB, Kapoor S, DeBlasis TL,
Freeman EW: Association of physical activity with reproductive
hormones: the Penn ovarian aging study. Cancer Epidemiol Biomarkers
Prev 2007, 16:2042–2047.
13. Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA, Hoover RN: Serum
hormone levels in relation to reproductive and lifestyle factors in
postmenopausal women (United States). Cancer Causes Control 1998,
9:199–207.
14. Van Gils CH, Peeters PH, Schoenmakers MC, Nijmeijer RM, Onland-Moret NC,
van der Schouw YT, Monninkhof EM: Physical activity and endogenous sex
hormone levels in postmenopausal women: a cross-sectional study in the
prospect-EPIC cohort. Cancer Epidemiol Biomarkers Prev 2009,
18:377–383.
15. Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J,
Acharya G, Oian P, Berntsen GK: Endogenous sex hormones in relation to
age, sex, lifestyle factors, and chronic diseases in a general population:
the tromso study. J Clin Endocrinol Metab 2004, 89:6039–6047.
16. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ: Circulating levels
of sex hormones and their relation to risk factors for breast cancer: a
cross-sectional study in 1092 pre- and postmenopausal women (United
Kingdom). Cancer Causes Control 2001, 12:47–59.
17. Wu F, Ames R, Evans MC, France JT, Reid IR: Determinants of sex
hormone-binding globulin in normal postmenopausal women.
Clin Endocrinol (Oxf ) 2001, 54:81–87.
18. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M: Body-mass index
and incidence of cancer: a systematic review and meta-analysis of
prospective observational studies. Lancet 2008, 371:569–578.
19. Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-
Mesquita HB, Johnsen SP, Overvad K, Olsen A, et al: C-peptide, IGF-I, sex-
steroid hormones and adiposity: a cross-sectional study in healthy
women within the European prospective investigation into cancer and
nutrition (EPIC). Cancer Causes Control 2005, 16:561–572.
20. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD: Associations of body
mass and fat distribution with sex hormone concentrations in
postmenopausal women. Int J Epidemiol 1991, 20:151–156.
21. Newcomb PA, Klein R, Klein BE, Haffner S, Mares-Perlman J, Cruickshanks KJ,
Marcus PM: Association of dietary and life-style factors with sex
hormones in postmenopausal women. Epidemiology 1995, 6:318–321.22. Monninkhof EM, Velthuis MJ, Peeters PH, Twisk JW, Schuit AJ: Effect of
exercise on postmenopausal sex hormone levels and role of body fat: a
randomized controlled trial. J Clin Oncol 2009, 27:4492–4499.
23. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen
B, Rudolph RE, Bowen D, Stanczyk FZ, et al: Effect of exercise on serum
estrogens in postmenopausal women: a 12-month randomized clinical
trial. Cancer Res 2004, 64:2923–2928.
24. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak
J, Stanczyk FZ, Bowen D, Irwin ML, et al: Effect of exercise on serum
androgens in postmenopausal women: a 12-month randomized clinical
trial. Cancer Epidemiol Biomarkers Prev 2004, 13:1099–1105.
25. Friedenreich CM, Woolcott CG, McTiernan A, Ballard-Barbash R, Brant RF,
Stanczyk FZ, Terry T, Boyd NF, Yaffe MJ, Irwin ML, et al: Alberta physical
activity and breast cancer prevention trial: sex hormone changes in a
year-long exercise intervention among postmenopausal women. J Clin
Oncol 2010, 28:1458–1466.
26. Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan
CR, Mason C, Imayama I, Kong A, Xiao L, et al: Reduced-calorie dietary
weight loss, exercise, and sex hormones in postmenopausal women:
randomized controlled trial. J Clin Oncol 2012, 30:2314–2326.
27. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-
Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS: Compendium of
physical activities: a second update of codes and MET values. Med Sci
Sports Exerc 2011, 2011(43):1575–1581.
28. Health Council of the Netherlands: Guidelines for a healthy diet 2006. Health
Council of the Netherlands: The Hague; 2006. publication no. 2006/21E.
29. Roza AM, Shizgal HM: The Harris Benedict equation reevaluated: resting
energy requirements and the body cell mass. Am J Clin Nutr 1984, 40:168–182.
30. Onland-Moret NC, Peeters PH, van der Schouw YT, Grobbee DE, Van Gils CH:
Alcohol and endogenous sex steroid levels in postmenopausal women: a
cross-sectional study. J Clin Endocrinol Metab 2005, 90:1414–1419.
31. Rinaldi S, Peeters PH, Bezemer ID, Dossus L, Biessy C, Sacerdote C, Berrino F,
Panico S, Palli D, Tumino R, et al: Relationship of alcohol intake and sex
steroid concentrations in blood in pre- and post-menopausal women:
the European prospective investigation into cancer and nutrition. Cancer
Causes Control 2006, 17:1033–1043.
32. Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner KB,
Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R: Dietary fiber
is associated with serum sex hormones and insulin-related peptides in
postmenopausal breast cancer survivors. Breast Cancer Res Treat 2008,
112:149–158.
33. Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS,
Hemmelgarn BR: Motivational interviewing to improve weight loss in
overweight and/or obese patients: a systematic review and meta-
analysis of randomized controlled trials. Obes Rev 2011, 12:709–723.
34. Miller WR, Rollnick S: Motivational interviewing: helping people change. New
York: Guilford Press; 2012.
35. Shaw K, O’Rourke P, Del MC, Kenardy J: Psychological interventions for
overweight or obesity. Cochrane Database Syst Rev 2005, 2:CD003818.
36. Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A,
Bain CE, Wang CY, Blackburn GL, McTiernan A: Effect of diet and exercise,
alone or combined, on weight and body composition in overweight-to
-obese postmenopausal women. Obesity (Silver Spring) 2012,
20:1628–1638.
37. Velthuis MJ, Schuit AJ, Peeters PH, Monninkhof EM: Exercise program
affects body composition but not weight in postmenopausal women.
Menopause 2009, 16:777–784.
38. King NA, Caudwell P, Hopkins M, Byrne NM, Colley R, Hills AP, Stubbs JR,
Blundell JE: Metabolic and behavioral compensatory responses to
exercise interventions: barriers to weight loss. Obesity (Silver Spring) 2007,
15:1373–1383.
39. Blundell JE, Stubbs RJ, Hughes DA, Whybrow S, King NA: Cross talk
between physical activity and appetite control: does physical activity
stimulate appetite? Proc Nutr Soc 2003, 62:651–661.
40. Byrne NM, Hills AP, Hunter GR, Weinsier RL, Schutz Y: Metabolic equivalent:
one size does not fit all. J Appl Physiol 2005, 99:1112–1119.
41. Kozey S, Lyden K, Staudenmayer J, Freedson P: Errors in MET estimates of
physical activities using 3.5 ml x kg(−1) x min(−1) as the baseline
oxygen consumption. J Phys Act Health 2010, 7:508–516.
42. Kohrt WM, Spina RJ, Holloszy JO, Ehsani AA: Prescribing exercise intensity
for older women. J Am Geriatr Soc 1998, 46:129–133.
van Gemert et al. BMC Cancer 2013, 13:395 Page 10 of 10
http://www.biomedcentral.com/1471-2407/13/39543. Tworoger SS, Yasui Y, Chang L, Stanczyk FZ, McTiernan A: Specimen
allocation in longitudinal biomarker studies: controlling subject-specific
effects by design. Cancer Epidemiol Biomarkers Prev 2004, 13:1257–1260.
44. Haring R, Hannemann A, John U, Radke D, Nauck M, Wallaschofski H, Owen
L, Adaway J, Keevil BG, Brabant G: Age-specific reference ranges for serum
testosterone and androstenedione concentrations in women measured
by liquid chromatography-tandem mass spectrometry. J Clin Endocrinol
Metab 2012, 97:408–415.
45. Stichting Huisartsenlaboratorium Oost. www.labsho.nl.
46. Dixon WT: Simple proton spectroscopic imaging. Radiology 1984,
153:189–194.
47. American Thoracic Society: American College of Chest Physicians. ATS/
ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit
Care Med 2003, 167:211–277.
48. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D: Reproducibility and
relative validity of the short questionnaire to assess health-enhancing
physical activity. J Clin Epidemiol 2003, 56:1163–1169.
49. Schuit AJ, Schouten EG, Westerterp KR, Saris WH: Validity of the physical
activity scale for the elderly (PASE): according to energy expenditure
assessed by the doubly labeled water method. J Clin Epidemiol 1997,
50:541–546.
50. Dutch Food Composition Database.; 2011. NEVO online version 2011/3.0,
RIVM, Bilthoven. http://nevo-online.rivm.nl/.
51. Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM: Meta-analysis: the
effect of dietary counseling for weight loss. Ann Intern Med 2007, 147:41–50.
52. Ashford S, Edmunds J, French DP: What is the best way to change self-
efficacy to promote lifestyle and recreational physical activity? a systematic
review with meta-analysis. Br J Health Psychol 2010, 15:265–288.
53. Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD:
Individual versus group therapy for obesity: effects of matching participants
to their treatment preferences. J Consult Clin Psychol 2001, 69:717–721.
54. Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O’Byrne MM, Port JD,
Tremaine WJ, Pitot HC, McFarland EG, Robinson ME, et al: Incidental
findings in imaging research: evaluating incidence, benefit, and burden.
Arch Intern Med 2010, 170:1525–1532.
55. Pinato DJ, Stavraka C, Tanner M, Esson A, Jacobson EW, Wilkins MR, Libri V:
Clinical, ethical and financial implications of incidental imaging findings:
experience from a phase I trial in healthy elderly volunteers. PLoS One
2012, 7:e49814.
56. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, Fletcher JG,
Georgieff MK, Hammerschmidt D, Hudson K, et al: Managing incidental
findings in human subjects research: analysis and recommendations.
J Law Med Ethics 2008, 36:219–248. 211.
doi:10.1186/1471-2407-13-395
Cite this article as: van Gemert et al.: Design of the SHAPE-2 study: the
effect of physical activity, in addition to weight loss, on biomarkers of
postmenopausal breast cancer risk. BMC Cancer 2013 13:395.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
